Product Images Glatiramer Acetate
View Photos of Packaging, Labels & Appearance
- Figure 1: Time to Second Exacerbation - 327c5127 6727 4cf8 acea 838e5f9af458 01
- Figure 2: Median Cumulative Number of Gd-Enhancing Lesions - 327c5127 6727 4cf8 acea 838e5f9af458 02
- Glatiramer Acetate Injection 20 mg/mL Carton Label - image 01
- Instructions for Use Figure A - image 02
- Instructions for Use Figure B - image 03
- Instructions for Use Figure C - image 04
- Instructions for Use Figure D - image 05
- Instructions for Use Figure E - image 06
- Instructions for Use Figure F - image 07
- Instructions for Use Figure G - image 08
- Instructions for Use Figure H - image 09
- Instructions for Use Figure I - image 10
- Instructions for Use Figure J - image 11
- Instructions for Use Figure K - image 12
- Instructions for Use Figure L - image 13
Product Label Images
The following 15 images provide visual information about the product associated with Glatiramer Acetate NDC 0378-6960 by Mylan Pharmaceuticals Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Figure 1: Time to Second Exacerbation - 327c5127 6727 4cf8 acea 838e5f9af458 01
This appears to be a table or chart with data related to medical research, specifically related to the use of glatiramer acetate in treating multiple sclerosis. The percentages appear to be related to the likelihood or frequency of a second exacerbation occurring, with a hazard ratio of 0%. The value of p is also given as 0.0005. The significance or implications of this data are not provided by the text.*
Figure 2: Median Cumulative Number of Gd-Enhancing Lesions - 327c5127 6727 4cf8 acea 838e5f9af458 02
This appears to be a comparison chart between Glatiramer Acetate and a placebo, with the values of 18 and 16 appearing under each option, likely representing some sort of measurement or evaluation. The chart also includes some symbols that may be related to statistical analysis. Without further context, the purpose or significance of this chart is not clear.*
Glatiramer Acetate Injection 20 mg/mL Carton Label - image 01
This appears to be a product label or description for a medication containing Glatiramer Acetate. It includes instructions for use via subcutaneous injection, details regarding storage requirements, dosage information, and information about the manufacturer and distribution.*
Instructions for Use Figure A - image 02
The text appears to be a list of items, including "Starps", "Blsposal", "Contaner", "Coton Bals", "Syrnge n Blster Package", and "RicanolWipss". The last item is unclear, and there is a reference to "Figure A" which cannot be evaluated without context. It is not clear what the purpose or context of this list is, so a useful description cannot be provided.*
Instructions for Use Figure B - image 03
Instructions for Use Figure C - image 04
This is a set of instructions for body waxing, specifying areas to avoid on the abdomen, back of hips, and arms, as well as the thighs. It notes areas around the belly button and upper hips should be avoided, as well as areas of fleshy skin on the back of the arms and the upper thighs. It provides a visual guide with a labeled Figure C.*
Instructions for Use Figure D - image 05
Instructions for Use Figure E - image 06
Instructions for Use Figure F - image 07
Instructions for Use Figure G - image 08
Instructions for Use Figure H - image 09
Instructions for Use Figure I - image 10
Instructions for Use Figure J - image 11
Instructions for Use Figure K - image 12
Instructions for Use Figure L - image 13
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
